CNH Partners LLC Buys Shares of 1,479,055 Syneron Medical Ltd. (NASDAQ:ELOS)

CNH Partners LLC purchased a new position in Syneron Medical Ltd. (NASDAQ:ELOS) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 1,479,055 shares of the medical equipment provider’s stock, valued at approximately $16,196,000.

Other hedge funds have also added to or reduced their stakes in the company. Jane Street Group LLC lifted its position in Syneron Medical by 117.9% in the 1st quarter. Jane Street Group LLC now owns 10,373 shares of the medical equipment provider’s stock valued at $109,000 after acquiring an additional 68,405 shares in the last quarter. PEAK6 Investments L.P. bought a new position in Syneron Medical in the 1st quarter valued at approximately $111,000. Citadel Advisors LLC lifted its position in Syneron Medical by 2.1% in the 1st quarter. Citadel Advisors LLC now owns 11,835 shares of the medical equipment provider’s stock valued at $125,000 after acquiring an additional 243 shares in the last quarter. ETF Managers Group LLC bought a new position in Syneron Medical in the 2nd quarter valued at approximately $155,000. Finally, Two Sigma Securities LLC bought a new position in Syneron Medical in the 1st quarter valued at approximately $164,000. 69.17% of the stock is currently owned by institutional investors and hedge funds.

Shares of Syneron Medical Ltd. (NASDAQ:ELOS) remained flat at $11.00 during midday trading on Tuesday. 3,905 shares of the company’s stock were exchanged. Syneron Medical Ltd. has a 52 week low of $6.18 and a 52 week high of $11.43. The firm’s 50 day moving average price is $10.90 and its 200-day moving average price is $10.14.

Separately, BidaskClub cut Syneron Medical from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th.

TRADEMARK VIOLATION WARNING: This report was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://ledgergazette.com/2017/10/17/cnh-partners-llc-acquires-new-holdings-in-syneron-medical-ltd-elos.html.

Other hedge funds have also added to or reduced their stakes in the company. Jane Street Group LLC lifted its position in Syneron Medical by 117.9% in the 1st quarter. Jane Street Group LLC now owns 10,373 shares of the medical equipment provider’s stock valued at $109,000 after acquiring an additional 68,405 shares in the last quarter. PEAK6 Investments L.P. bought a new position in Syneron Medical in the 1st quarter valued at approximately $111,000. Citadel Advisors LLC lifted its position in Syneron Medical by 2.1% in the 1st quarter. Citadel Advisors LLC now owns 11,835 shares of the medical equipment provider’s stock valued at $125,000 after acquiring an additional 243 shares in the last quarter. ETF Managers Group LLC bought a new position in Syneron Medical in the 2nd quarter valued at approximately $155,000. Finally, Two Sigma Securities LLC bought a new position in Syneron Medical in the 1st quarter valued at approximately $164,000. 69.17% of the stock is currently owned by institutional investors and hedge funds.

Shares of Syneron Medical Ltd. (NASDAQ:ELOS) remained flat at $11.00 during midday trading on Tuesday. 3,905 shares of the company’s stock were exchanged. Syneron Medical Ltd. has a 52 week low of $6.18 and a 52 week high of $11.43. The firm’s 50 day moving average price is $10.90 and its 200-day moving average price is $10.14.

Separately, BidaskClub cut Syneron Medical from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th.

TRADEMARK VIOLATION WARNING: This report was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://ledgergazette.com/2017/10/17/cnh-partners-llc-acquires-new-holdings-in-syneron-medical-ltd-elos.html.

About Syneron Medical

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Institutional Ownership by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.